Troriluzole

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

4 Countries

Phase III

Phase II/III

Phase III: 2 Phase II/III: 1

Oversight events:

2 temporary halts across 1 trial

View oversight register →

Indications tested

Sponsors using this IMP

Biohaven Therapeutics Ltd. 2 Global Coalition For Adaptive Research Inc. 1

All trials

3 total

Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent Glioblastoma (GBM) Ended

2024-511452-40-00 Phase II/III 2 countries Global Coalition For Adaptive Research Inc.
Long-term Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder Ended

2024-512108-20-00 Phase III 2 countries Biohaven Pharmaceuticals Inc.
A research study investigating troriluzole as a possible treatment for Obsessive Compulsive Disorder Ended

2024-514585-39-00 Phase III 2 countries Biohaven Pharmaceuticals Inc.

Showing 1–3 of 3 trials

← All drugs A–Z